SUV39H1 regulates corneal epithelial wound healing via H3K9me3-mediated repression of p27
Eye and Vision volume 9, Article number: 4 (2022)
Corneal epithelial wound healing (CEWH) is vital for maintaining the integrity and barrier function of the cornea. Although histone modifications mediating gene expression patterns is fundamental in some other tissues, it remains unclear whether these gene regulation patterns underlie CEWH. Suppressor of variegation 3-9 homolog 1 (SUV39H1) plays a vital role in mediating gene silencing via histone H3 trimethylation of lysine 9 (H3K9me3). This study aims to characterize the comprehensive signature of epigenetic modifiers and determine the role of SUV39H1 in CEWH.
NanoString nCounter technology was used to detect the differentially expressed epigenetic modifiers during CEWH. Bioinformatic analyses were performed to reveal their involvement in this process. After knockdown of SUV39H1 with siRNA transfection, we determined the function of SUV39H1 on cell proliferation and migration in human corneal epithelial cells (HCECs) via MTS, EdU, and wound-healing assay, respectively. Flow cytometry analysis further confirmed the effect of SUV39H1 on the cell cycle of HCECs. Loss-of-function assays for SUV39H1 with siRNA injection or chaetocin assessed the role of SUV39H1 on CEWH in vivo. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) and Western blotting characterized the expression of SUV39H1 and its target genes. Chromatin immunoprecipitation assay was used to evaluate the distributions of H3K9me3 marks at the promoters of SUV39H1 target genes.
We first identified 92 differentially expressed epigenetic modifiers and revealed their involvement during CEWH. SUV39H1 was confirmed to be upregulated in response to corneal injury. Its downregulation significantly inhibited HCEC proliferation and retarded in vivo CEWH. Furthermore, knockdown of SUV39H1 upregulated the p27 expression level and reduced H3K9me3 marks at p27 promoter in HCECs. In addition, p27 was remarkably downregulated with elevated H3K9me3 marks at its promoter during in vivo CEWH.
SUV39H1 plays a critical role in regulating corneal epithelial cell proliferation via H3K9me3-mediated suppression of p27 during CEWH. Our findings suggest that epigenetic modifiers such as SUV39H1 can be potential therapeutic approaches to accelerate corneal repair.
Corneal structural integrity and transparency maintenance are both critical for preserving normal vision. The outermost epithelial layer of the cornea contributes to this process by providing a tight functional barrier against pathogenic stromal infiltration. Injury-induced declines in epithelial integrity compromise its barrier function, which renders the cornea susceptible to pathogenic infiltration, neovascularization, ulceration, and scarification [1, 2]. Corneal epithelial wound healing (CEWH) is a complex and multifactorial tissue rebuilding process that depends on cell proliferation, migration, differentiation, and stratification . These orchestrated cellular processes are, in part, controlled by numerous time-dependent modulation of selective gene activation and repression, such as integrins, growth factors, and cytokines [3,4,5]. Thus, it is crucial to clarify how the differential gene expression is regulated and coordinated.
Epigenetic regulations convey the heritability of gene expression patterns without altering DNA sequences , including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs). These epigenetic mechanisms are universal and efficient approaches to regulate gene expression during development and diseases [7,8,9]. Our recent research revealed that DNA methylation regulates CEWH by targeting miR-200a and CDKN2B . An important indication of histone modification involvement in corneal repair was when suberoylanilide hydroxamic acid (SAHA) showed an inhibitory effect on corneal neovascularization via repressing histone deacetylase-mediated hemangiogenesis and inflammation pathways . Furthermore, deficiency of a histone deacetylase Sirt6 delayed corneal epithelial wound closure which resulted in excessive inflammation in the corneal stroma . MicroRNA (miRNA) is another epigenetic modulator whose changes in expression levels affect CEWH in mice . It is noteworthy that these epigenetic mechanisms are implemented by various epigenetic modifiers [14,15,16,17]. However, little is known about whether histone modifiers contribute to regulating CEWH.
The suppressor of variegation 3-9 homolog 1 (SUV39H1) is a critical histone methyltransferase that catalyzes histone H3 lysine 9 trimethylation (H3K9me3) formation . H3K9me3 is a prominent determinant of heterochromatin formation and is a hallmark of transcriptionally silent genes [19, 20]. As the homologous protein of SUV39H1, SUV39H2 shares 59% identity with it, has similar structure and enzyme activity in mice, and displays testis-specific expression . The extent of gene expression suppression by SUV39H1 is dependent on its catalytic activity in mediating H3K9me3 [22,23,24]. For example, loss of SUV39H1 leads to an increase of E-cadherin expression by decreasing H3K9me3 marks at its promoter and ultimately inhibits breast cancer cell migration . In addition, parafibromin recruits SUV39H1 to catalyze H3K9me3 marks at the cyclin D1 promoter and decreases its expression which restrains cell proliferation . Interestingly, SUV39H1 and CTIP2 cooperate to silence p21 gene transcription through increasing H3K9me3 at its promoter, which accelerates cell proliferation . Besides, SUV39H1 represses MyoD-dependent muscle gene myogenin expression, which inhibits differentiation of proliferating muscle cells . All these findings indicate that SUV39H1 plays critical roles in controlling diverse biological processes, including cell migration, proliferation, and differentiation via H3K9me3-mediated transcriptional repression. However, it is unclear whether such a regulatory mechanism affects CEWH.
We show here that corneal epithelial injury activates SUV39H1 expression. Loss of SUV39H1 function remarkably inhibits HCEC proliferation by perturbing cell cycle processes in vitro and delays CEWH in vivo. Mechanistically, SUV39H1 upregulation accompanies the cyclin-dependent kinase inhibitor (CDKI) p27 downregulation resulting from a gain of H3K9me3 marks at its promoter during CEWH. Conversely, knockdown of SUV39H1 increases p27 expression level in human corneal epithelial cells (HCECs). This increased p27 expression is attributable to the reduction of H3K9me3 marks at its promoter. Collectively, our findings highlight the importance of SUV39H1 during CEWH and suggest it can be a potential candidate for hastening CEWH.
Corneal epithelial wound healing model
As previously described , eight-week-old C57BL/6 mice were anesthetized by intraperitoneal (i.p.) injection of xylazine (13 mg/kg) in combination with ketamine (87 mg/kg). Under a stereomicroscope, we used Algerbrush II (The Alger Company Inc., Lago Vista, TX, USA) to debride the corneal epithelium of the right eyes, which were referred to the wound healing group. The uninjured left eyes were served as the normal control group. The corneal epithelial layers were collected for RNA and protein extraction from these two different groups when the unrepaired area was approximately 10% of its initial area.
All animal treatments were performed in strict accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and approval from Wenzhou Medical University Animal Care and Use Committee.
NanoString nCounter assay and bioinformatic analyses
A customized mouse epigenetic regulator assay kit (nCounter v1.3; NanoString Technologies Inc., Seattle, WA, USA) was chosen based on current descriptions of epigenetic regulatory mechanisms. It contains 336 epigenetic modifiers involved in the control of DNA methylation, histone modifications, chromatin remodeling, microRNA biogenesis, and 14 housekeeping genes (Additional file 10: Table S1). Six CEWH mice were used for NanoString nCounter analysis. Total RNA (100 ng) extracted from each mouse corneal epithelium were used to establish digital epigenetic modifier profiling in accordance with the manufacturer’s instructions and the previous study . Expression patterns of epigenetic modifiers were analyzed as previously described . The Cluster 3.0 (Eisen Lab, University of California at Berkeley, CA, USA) was used to perform Hierarchical Clustering and the results were visualized in a clustered heat map using TreeView (Eisen Lab, University of California at Berkeley, CA, USA). The differentially expressed epigenetic modifiers were filtered with a limma algorithm , and selected following these criteria: (1) P < 0.05, false discovery rate (FDR) < 0.05; (2) fold change > 1.5 or < 0.5. Subsequently, data were clustered in terms of Euclidian distance and Z-score was used to normalize each row. Furthermore, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed on the differentially expressed epigenetic modifiers.
Quantitative reverse transcription polymerase chain reaction (RT-qPCR)
Total RNA was isolated from freshly harvested corneal epithelium or cultured HCECs using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Complementary DNA (cDNA) was then produced using the Reverse Transcription Kit (Promega Corp., Madison, WI, USA). RT-qPCR was carried out using Power SYBR Green PCR Master Mix (Thermo Fisher Scientific, Waltham, MA, USA) on the 7500 Fast Real-Time PCR System (Thermo Fisher Scientific). β-actin or GAPDH was used as the endogenous control to normalize the relative expression of target genes, which were further analyzed and expressed based on the 2−ΔΔCt method (see Additional file 11: Table S2 for primer sequences).
Western blotting analysis
RIPA lysis buffer (Beyotime Biotechnology Inc., Shanghai, China) was used for total protein extraction from freshly harvested corneal epithelium or cultured HCECs, and total protein concentration was determined with the Pierce™ Rapid Gold BCA Protein Assay Kit (Thermo Fisher Scientific). Western blotting was performed as previously described . Antibodies for H3K9me3 (Diagenode Inc., pAb-056-050, Denville, NJ, USA), p27 (Cell Signaling Technology, 3686, Beverly, MA, USA), p-Rb (Cell Signaling Technology, 8516), β-actin (Cell Signaling Technology, 3700), GAPDH (Cell Signaling Technology, 5174), SUV39H1 (Merck Millipore, 07-550, Billerica, MA, USA), p21 (Merck Millipore, 05-345), and SUV39H2 (Abcam, ab190870, Cambridge, MA, USA) were used to label their target proteins. Protein bands were analyzed using ImageJ software (1.46r, Wayne Rasband, National Institutes of Health, Bethesda, MD, USA).
Cell culture and siRNA transfection
HCECs were cultured in DMEM/F12 medium (Invitrogen) containing 10% fetal bovine serum (Invitrogen) at 37℃ with 5% CO2, as previously reported . Depending on the experimental requirements, different amounts of HCECs were seeded onto appropriate sizes of tissue culture containers. SUV39H1 and/or SUV39H2 siRNA (50 nM, Sigma-Aldrich, St Louis, MO, USA) or negative control (NC) were transfected into HCECs using Lipofectamine RNAiMAX (Invitrogen).
Cell proliferation assay
3 × 103 HCECs were seeded onto each designated well of 96-well plate (Corning Inc., Corning, NY, USA) for the transfection of 50 nM SUV39H1 and/or SUV39H2 siRNA or NC. After 24-h transfection, the MTS assay kit (Promega) was used to quantify cell proliferation according to the manufacturer's instructions. In addition, HCEC proliferation was determined by using the Click-iT™ EdU Alexa Fluor 594 Imaging Kit (Invitrogen) as previously described . The fluorescence intensity was detected and analyzed via MD ImageXpress Micro (Molecular Devices, San Jose, CA, USA).
Double thymidine block (DTB) and cell cycle distribution analysis
HCECs were synchronized in the G1-phase using double thymidine block as published previously [31, 32]. 4 × 105 HCECs were seeded onto a six-well plate (Corning) and transfected with 50 nM SUV39H1 and/or SUV39H2 siRNA or NC. Transfected HCECs were cultured in DMEM/F12 medium containing 2 mmol/L thymidine (Sigma-Aldrich) for 16 h for the first blocking. Then, HCECs were cultured in normal DMEM/F12 medium without thymidine for 9 h after washing twice with PBS. Subsequently, HCECs were treated with 2 mmol/L thymidine for another 16 h for the second blocking. Afterward, the double-blocked HCECs were released by washing twice with PBS and then incubated in thymidine-free medium. The synchronized HCECs were collected to stain with propidium iodide (PI) and analyzed for DNA content with a fluorescence activated cell sorting (FACS) caliber (Becton Dickinson) at 0 h, 6 h, 8 h, 10 h, 12 h, 14 h, 16 h, 18 h, and 24 h after release from the DTB.
In vitro scratch wound assay
1.2 × 105 HCECs were plated onto a 12-well plate (Corning) and transfected with either 50 nM SUV39H1 siRNA and/or SUV39H2 siRNA or NC at approximately 30% confluence. After 48 h, HCECs were wounded with a 100 μL pipette tip and cultured in 1 ml fresh serum-free DMEM/F12 medium. Cell migration was monitored based on photographs of remaining open areas in the cell cultures (Imager Z1; Zeiss, Jena, Germany) and quantified at 0 h and 24 h after scratching with ImageJ software. The initially injured area was designated as S0h, and the remaining injured area at 24 h after scratching was referred to as S24h. Accordingly, percentage of cell migration = (S0h − S24h)/S0h × 100%.
Flow cytometry analysis of p-Rb and CDK6 in HCECs
4 × 105 HCECs were seeded onto a six-well plate and transfected with 50 nM SUV39H1 or NC. Transfected HCECs were collected to perform FACS with Intracellular Flow Cytometry Kit (Cell Signaling Technology) according to the manufacturer's protocol. Briefly, HCECs were fixed with 4% formaldehyde for 15 min at room temperature. After washing with PBS, fixed HCECs were stored at − 20 °C in 90% methanol overnight. Then, HCECs were incubated with antibodies of phospho-Rb (Alexa Fluor® 488 Conjugate, 4277, Cell Signaling Technology) or CDK6 (Alexa Fluor® 488 Conjugate, ab198944, Abcam) or IgG (Alexa Fluor® 488 Conjugate, ab150077, Cell Signaling Technology) for 1 h. Furthermore, HCECs were resuspended in PBS after washing and analyzed with the Accuri™ C6 Plus (Becton Dickinson). The FlowJo software (Tree Star Inc., Ashland, OR, USA) was used to analyze the data.
Loss-of-function assays for SUV39H1 in vivo
Loss-of-function of SUV39H1 was performed by inhibiting its enzymatic activity with chaetocin (Selleck Chemicals Inc., Houston, TX, USA) or gene silencing via corneal intrastromal SUV39H1 siRNA injection. Here, we established CEWH models by debriding the corneal epithelium with an Algerbrush II under a stereomicroscope after demarcating a 2-mm wide corneal epithelial area with a 2-mm trephine in both right and left eyes. After creating the wound, 50 μM chaetocin was instilled into the right eyes every 2 h, whereas the contralateral control group eyes were treated with physiological saline at the same time intervals. In addition, SUV39H1 gene silencing was carried out following an established method for siRNA delivery into the corneal epithelial layer [10, 33]. We used a 33-gauge needle (Hamilton, Bonaduz, Switzerland) to inject SUV39H1 siRNA (100 μM) or NC (100 μM) in a complex with polyethylenimine (PEI; Polyplus-transfection, New York, NY, USA) into the anterior stroma of the corneas under a stereomicroscope. The right eyes were injected with SUV39H1 siRNA as the experimental group; meanwhile, the left eyes were injected with NC as the control group. The 2-mm wide wounds were created in both right and left eyes approximately 6 h after intrastromal siRNA injection as described above. The cornea’s wounded area was demarcated with fluorescein sodium-staining and quantified at 0 h and 24 h with the ImageJ software.
Chromatin immunoprecipitation (ChIP) assay
HCECs were plated in 6-cm diameter dishes and transfected with either 50 nM SUV39H1 siRNA or NC at approximately 30% confluence. HCECs were harvested 48 h later after siRNA transfection to perform ChIP assay using Magna ChIP™ A/G kit (Merck Millipore) according to the manufacturer’s guidelines. In brief, we sonicated the cross-linked chromatin into 200 to 1000 base pair fragments with Covaris M220 Focused-ultrasonicator™ (Thermo Fisher Scientific). Sheared chromatins were immunoprecipitated using H3K9me3 antibody (Diagenode Inc., pAb-056-050) or SUV39H1 antibody (Merck Millipore, 05615). ChIP-derived DNA was quantified by quantitative PCR using Power SYBR Green PCR Master Mix. With the similar procedure, the corneal epithelium was collected for ChIP assay to evaluate the distributions of H3K9me3 marks at candidate gene promoters during CEWH. Data are analyzed and expressed as a percentage of input signal using the 2−ΔCt method (see Additional file 12: Table S3 for primer sequences).
All data were analyzed using a Student's t-test or one-way ANOVA with Bonferroni correction in multiple groups to determine statistically significant differences. A P value less than 0.05 was taken as statistical significance (*P < 0.05, **P < 0.01, ***P < 0.001). All data is provided as mean ± standard error of the mean (SEM).
Systematic analysis of epigenetic regulator profile during CEWH
Until now, the precise role of epigenetic regulations in CEWH is still incompletely understood. Therefore, we performed a comprehensive analysis to gain insight into the epigenetic regulatory mechanisms underlying this process. To ascertain if epigenetic modifiers are involved in CEWH, we applied NanoString nCounter technology to determine if 336 documented epigenetic modifiers contribute to regulating this process in six mice. We found that 45 epigenetic modifiers were markedly upregulated whereas 47 other epigenetic modifiers were significantly downregulated (Additional file 13: Table S4). The 60 most differentially altered epigenetic modifiers were hierarchically clustered and displayed as a heat map (Fig. 1). As indicated, most of these distinct modifiers are histone modification regulators or chromatin remodeling factors, suggesting that histone modifications and chromatin remodeling play essential roles during CEWH.
Bioinformatic analyses reveal the potential role of epigenetic regulators in CEWH
We then conducted GO and KEGG pathway enrichment analyses using these differentially expressed epigenetic modifiers. As shown in Additional file 1: Fig. S1, GO enrichment analysis showed that histone modifications were predominant, such as histone H3-K36 methylation, histone arginine methylation, histone H3-K36 demethylation, and histone H3-K9 trimethylation in GO biological process terms. Consistent with these, H3 histone acetyltransferase complex, histone methyltransferase complex, and histone deacetylase complex in GO cellular component terms were enriched during CEWH. Besides, histone demethylase activity (H3-K4 or H3-K36 specific) and histone methyltransferase activity (H3-K9 or H3-K36 specific) in GO molecular function terms were also enriched during CEWH. Furthermore, KEGG pathway enrichment analysis showed that epigenetic modifiers may regulate CEWH through controlling a complex network of various signaling pathways, including those involving cell cycle control, mitogen-activated protein kinase (MAPK), and Wnt signaling pathways (Additional file 2: Fig. S2).
Both SUV39H1 and SUV39H1 are significantly up-regulated during CEWH
Among these differentially expressed epigenetic modifiers appearing during CEWH, the significantly upregulated SUV39H1 and SUV39H2 attracted our attention because of their crucial roles in regulating diverse cellular processes via H3K9me3 [18, 21]. RT-qPCR confirmed the upregulation of both SUV39H1 and SUV39H2 mRNA levels during CEWH (Fig. 2a). Such mRNA increases were accompanied by corresponding increases in their protein levels during this process (Fig. 2b).
SUV39H1 is an effective modulator of HCEC proliferation
To determine the functional roles of SUV39H1/2 during CEWH, we selectively knocked them down by siRNA transfection in HCECs. This procedure reduced SUV39H1 and SUV39H2 mRNA levels by 84% and 77%, respectively, relative to their control levels (Fig. 3a). In agreement with these declines, SUV39H1 and SUV39H2 protein levels were also significantly decreased (Fig. 3b). MTS assay showed that SUV39H1 siRNA transfection significantly reduced HCEC proliferation at 48 h and 72 h of culture, compared with the control group (Fig. 3c). Such declines were confirmed by showing that SUV39H1 knockdown remarkably decreased EdU-positive HCECs (Fig. 3d–e). Furthermore, double thymidine block and release experiments were carried out to evaluate the effect of SUV39H1 knockdown on HCEC cell cycle distribution (Additional file 3: Fig. S3). The decreases in cell proliferation agree with the rise in the proportion of cells arrested at the G1 phase of SUV39H1 siRNA transfected HCECs compared with their proportional distribution pattern in their NC counterpart at 24 h after release from double thymidine block (Fig. 3f). However, SUV39H2 siRNA transfection did not show any significant effects on cell proliferation and cell cycle (Fig. 3c–f). In addition, knockdown of SUV39H1 with another SUV39H1 siRNA also inhibited HCEC proliferation and induced G1 cell cycle arrest (Additional file 4: Fig. S4).
HCEC migration is unaltered by SUV39H1 or SUV39H2 knockdown
To evaluate the effects of SUV39H1 and SUV39H2 on HCEC migration, we determined whether the time required for wound closure is different between SUV39H1 or SUV39H2 siRNA transfected cells and the NC group. The results showed no significant difference in cell migration between either the SUV39H1 knockdown or the SUV39H2 knockdown groups and their corresponding NC group (Fig. 4).
Suppression of SUV39H1 delays in vivo CEWH
To explore the physiological relevance of the results showing that SUV39H1 is an epigenetic modulator of CEWH in vitro, we determined if an inhibitor of SUV39H1 enzymatic activity, chaetocin, alters CEWH in vivo. A corneal epithelial debridement wound was created in both right and left murine eyes, respectively. Then, chaetocin was instilled into the right eyes every 2 h whereas the contralateral control eyes were treated with physiological saline. Strikingly, the wound closure was delayed in the chaetocin-treated corneas compared to the control group (Fig. 5a, b). Furthermore, we confirmed this delay in wound closure by showing that the remaining wound area was larger in the SUV39H1 siRNA-injected corneas than the NC (Fig. 5c, d). The efficiency of siRNA-mediated knockdown was confirmed by RT-qPCR analysis (Additional file 5: Fig. S5). Similarly, injection with a different siRNA against SUV39H1 into the cornea also reduced SUV39H1 expression and remarkedly delayed corneal epithelial wound closure (Additional file 6: Fig. S6). Taken together, these data demonstrated that SUV39H1 loss of function effectively inhibits CEWH in vivo.
SUV39H1 modulates cell cycle progression through targeting p27 and p21
To clarify how SUV39H1 knockdown inhibits cell cycle progression and proliferation of HCECs, we determined its effect on the expression of key proteins associated with regulating G1-S transition . p27 and p21 were identified as candidate genes for further analysis (Additional file 7: Fig. S7). As shown in Fig. 6a, b, p27, and p21 protein levels were upregulated in SUV39H1 siRNA-transfected HCECs compared with the NC. Moreover, knockdown of SUV39H1 downregulated p-Rb, but the levels of p15 were nearly invariant. In addition, SUV39H1 repression also reduced cyclin D1 and CDK6 in HCECs (Additional file 8: Fig. S8). Furthermore, downregulation of p-Rb and CDK6 in the SUV39H1 siRNA-transfected HCECs was confirmed by FACS (Additional file 8: Fig. S8). Given that SUV39H1 suppresses gene transcription via H3K9me3 [23, 24], we assumed that p27 and p21 are candidate target genes of SUV39H1 in HCECs. As predicted, SUV39H1 siRNA transfection significantly increased p21 and p27 mRNA levels when compared with NC (Fig. 6c). Furthermore, ChIP assay demonstrated that SUV39H1 knockdown significantly reduced H3K9me3 marks at the p27 promoter (− 780 to − 575 nt) and p21 promoter (− 544 to − 370 nt) around the transcription start sites (Fig. 6d, e), consistent with the reduced SUV39H1 binding at their promoters (Additional file 9: Fig. S9).
SUV39H1 represses p27 via increasing H3k9me3 marks at its promoter during CEWH
To confirm whether SUV39H1 regulates p27 and p21 during CEWH, we performed Western blotting and RT-qPCR analysis. The results indicated that the p27 expression level significantly declined in the wound healing group, whereas SUV39H1 mRNA and protein levels were upregulated when compared with the control group (Fig. 7a–c). On the other hand, the p21 expression level appeared unaltered. Furthermore, the H3K9me3 marks at different regions of the p27 promoter in the corneal epithelium were significantly upregulated after injury compared with the normal control (Fig. 7d–e). Overall, our data establish a regulatory mechanism of SUV39H1-mediated repression of p27 during CEWH both in vitro and in vivo.
Corneal epithelial renewal is a complex response entailing time-dependent expression modulation of numerous genes controlling cell proliferation, migration, and differentiation [4, 35]. Emerging evidence suggests that different epigenetic mechanisms contribute to the control of gene expression [36, 37], which are precisely implemented by distinct epigenetic modifiers. Recent studies have revealed that DNA methylation and miRNAs indeed regulate CEWH [10, 13, 38]. However, there are few reports systematically describing the roles of histone modifier alteration in modulating this process.
In a previous study, we adopted NanoString nCounter technology to characterize an accurate miRNA signature during CEWH. Here, we expanded our interest to include a more comprehensive portfolio of epigenetic modifiers. The NanoString nCounter analysis precisely identified 92 epigenetic regulators that were significantly altered during CEWH. Among these epigenetic modifiers, UHRF1 and TET3 are associated with DNA methylation [39, 40], suggesting a dynamic change of DNA methylation is also involved in CEWH. In addition, histone H3 variant CENPA and histone H2 variant H2AFX underwent upregulation during CEWH. Besides, corneal injury upregulated KDM8 which functions as a transcriptional activator by demethylating H3K36me2 . Interestingly, KDM8 was also overexpressed during skin injury repair in rats . In addition, histone deacetylases (HDACs) such as HDAC11 and HDAC10 are markedly downregulated in response to corneal injury, suggesting that histone acetylation mediated gene activation is important for CEWH. In tandem with this, HDAC inhibitor valproic acid can promote spinal cord injury repair by upregulating the expressions of Hsp70 and Bcl-2 in rats . Similarly, another HDAC inhibitor, trichostatin A can accelerate the digit regeneration in mice . Specifically, corneal injury resulted in an upregulation of histone methyltransferase SUV39H1 and SUV39H2, which control the methylation status of H3K9me3 , a well-established epigenetic repressive mark. To the best of our knowledge, this study is the first to provide a comprehensive and precise epigenetic modifier signature during CEWH. Such data will assuredly be a valuable resource for researchers in this field.
Further GO analysis demonstrated that most of these epigenetic modifiers were correlated with histone covalent modifications, such as histone H3-K9 trimethylation, suggesting that histone modifications are crucial contributors in regulating CEWH. Additionally, KEGG pathway analysis showed that the WNT and MAPK signaling pathways and cell cycle progression were activated in response to corneal epithelial injury, which is consistent with our previous report . Therefore, our data demonstrated that corneal injury stimulates the alteration of epigenetic modifier expression, which suggests that epigenetic mechanisms are widely involved in regulating CEWH.
Previous studies demonstrated that SUV39H1/2 can regulate cell proliferation and migration [25, 46,47,48]. Both of these responses are vital for the rate of CEWH process . One of our approaches to characterize the role of SUV39H1/2 in mediating CEWH entailed determining the effects of the loss of SUV39H1/2 function on HCEC proliferation and migration. MTS and EdU staining demonstrated that SUV39H1 silencing significantly inhibited HCEC proliferation. These declines are consistent with the retardation of cell cycle progression because downregulation of SUV39H1 increased the proportion of HCECs in the G1 phase. These effects agree with those showing that SUV39H1 knockdown also inhibited proliferation in other cell lines, such as GOS-3 and T98G glioma cells . It is noteworthy that SUV39H2 knockdown had no inhibitory effects on either HCEC proliferation or cell cycle progression, which may be caused by the diverse tissue-specific effects of SUV39H1/2 in different cells and tissues. Yokoyama et al. found that overexpression of SUV39H1 activated migration in breast and colorectal cancer cells . This finding is partly consistent with another recent report in which knockdown of Suv39H1 restored E-cadherin expression and inhibited cell migration of basal-like breast cancer . In addition, Huang et al. revealed that SUV39H2 contributes to cell proliferation and metastasis of colon cancer via increasing H3K9me3 marks at the SLIT1 promoter . Above all, we identified that SUV39H1 acts as an epigenetic regulator of HCEC proliferation rather than SUV39H2. Moreover, our results suggest that wound-induced SUV39H1 upregulation mediates increases in mouse corneal epithelial cell proliferation in vivo.
In 2005, Greiner et al. showed that chaetocin selectively inhibited histone methyltransferase SU(VAR)3–9 over a narrow concentration range . In this study, we found that chaetocin can significantly delay mouse CEWH, which supports the notion that SUV39H1 has an essential role in stimulating corneal epithelial proliferation and wound healing. However, chaetocin was also reported to inhibit another histone methyltransferase G9a besides SUV39H1 at higher concentrations which may blunt increases in corneal epithelial cell proliferation [52, 53]. To confirm the involvement of SUV39H1 in modulating cell proliferation and CEWH, these responses to injury were further evaluated in vivo using SUV39H1 siRNA injection to decrease its expression. This procedure dramatically retarded corneal wound closure where we saw a 50% decline in the expression of SUV39H1 after specific siRNA injection, supporting the notion that elevated SUV39H1 expression has a direct effect on promoting CEWH in mice.
It is well-known that cell proliferation is dependent on cell cycle control [34, 54]. Chung et al. found that corneal epithelial debridement stimulates synchronization of the G1/S transition of basal cells into the cell cycle . This finding is partly consistent with our result that silencing SUV39H1 led to G1 cell cycle arrest in HCECs. Progression through the G1 phase and G1/S checkpoint is dependent on CDK4, CDK6, and CDK2 activation, as well as their interactions with corresponding cyclin co-factors. On the other hand, CDKIs such as p27 and p21 can effectively inhibit cyclin-CDK complex activity, and thus impede transit through the G1/S checkpoint . In this study, SUV39H1 knockdown led to the upregulation of p27 and p21, and downregulation of Cyclin D1 and CDK6 in HCECs. These alterations then suppressed transit through the G1/S checkpoint through a decrease in Rb phosphorylation in HCECs, which is a critical mediator in the control of cell proliferation [56, 57]. It is well-established that the repressive control of gene expression by SUV39H1 is mediated through modulating H3K9me3 marks on the target gene promoters [22,23,24]. In a previous study, SUV39H1 was recruited to the p21 gene promoter and repressed its expression via increasing H3K9me3 marks in microglial cells . Consistent with these findings, we observed that knockdown of SUV39H1 significantly reduced H3K9me3 marks and SUV39H1 binding at the p27 and p21 promoters around transcription start sites in HCECs. The importance of p27 modulation to the control of proliferation during CEWH is substantiated by another report showing that p15 and p27 expression levels dramatically declined while p21 expression did not appear to change after corneal injury . Indeed, the downregulation of p27 expression accompanied SUV39H1 upregulation during CEWH. In parallel with this reciprocal relationship between changes in SUV39H1 and p27 expression levels, the H3K9me3 marks at p27 promoter were significantly increased during CEWH, suggesting that p27 is indeed a target gene of SUV39H1. To sum up, our findings reveal that wound-induced increase in SUV39H1 expression has a corresponding effect on cell proliferation through H3K9me3-mediated repression of p27 both in vitro and in vivo. Further studies are warranted to elucidate the detailed mechanism that accounts for how SUV39H1 affects p27 expression through modulating H3K9me3 marks at the p27 promoter during CEWH.
We identify a comprehensive signature of epigenetic modifiers during CEWH in mice. Upregulation of SUV39H1 promotes CEWH through regulating cell proliferation which is mediated through increased H3K9me3 marks at the p27 promoter and in turn suppressed its expression. Our findings point to the possibility that epigenetic modifiers such as SUV39H1 can be served as potential targets for promoting CEWH.
Availability of data and materials
All data generated or analyzed during this study are included in this published article along with the relevant supplementary files.
Corneal epithelial wound healing
Suppressor of variegation 3-9 homolog 1
Histone H3 lysine 9 trimethylation
Human corneal epithelial cell
Suberoylanilide hydroxamic acid
Cyclin-dependent kinase inhibitor
False discovery rate
Kyoto Encyclopedia of Genes and Genomes
Quantitative reverse transcription polymerase chain reaction
Double thymidine block
Fluorescence activated cell sorting
Standard error of the mean
Mitogen-activated protein kinase
Sharif Z, Sharif W. Corneal neovascularization: updates on pathophysiology, investigations and management. Rom J Ophthalmol. 2019;63(1):15–22.
Garg P, Rao GN. Corneal ulcer: diagnosis and management. Community Eye Health. 1999;12(30):21–3.
Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17–45.
Liu CY, Kao WW. Corneal epithelial wound healing. Prog Mol Biol Transl Sci. 2015;134:61–71.
Stepp MA, Zieske JD, Trinkaus-Randall V, Kyne BM, Pal-Ghosh S, Tadvalkar G, et al. Wounding the cornea to learn how it heals. Exp Eye Res. 2014;121:178–93.
Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17(8):487–500.
Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–54.
Weng KF, Hung CT, Hsieh PT, Li ML, Chen GW, Kung YA, et al. A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cells. Nucleic Acids Res. 2014;42(20):12789–805.
Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447(7143):433–40.
Luo G, Jing X, Yang S, Peng D, Dong J, Li L, et al. DNA methylation regulates corneal epithelial wound healing by targeting miR-200a and CDKN2B. Invest Ophthalmol Vis Sci. 2019;60(2):650–60.
Li X, Zhou Q, Hanus J, Anderson C, Zhang H, Dellinger M, et al. Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model. Mol Pharm. 2013;10(1):307–18.
Hu X, Zhu S, Liu R, Miller JD, Merkley K, Tilton RG, et al. Sirt6 deficiency impairs corneal epithelial wound healing. Aging (Albany NY). 2018;10(8):1932–46.
An J, Chen X, Chen W, Liang R, Reinach PS, Yan D, et al. MicroRNA expression profile and the role of miR-204 in corneal wound healing. Invest Ophthalmol Vis Sci. 2015;56(6):3673–83.
Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38.
Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463(7280):474–84.
Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–24.
Gordon JAR, Stein JL, Westendorf JJ, van Wijnen AJ. Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease. Bone. 2015;81:739–45.
Firestein R, Cui X, Huie P, Cleary ML. Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol Cell Biol. 2000;20(13):4900–9.
Becker JS, Nicetto D, Zaret KS. H3K9me3-dependent heterochromatin: barrier to cell fate changes. Trends Genet. 2016;32(1):29–41.
Bulut-Karslioglu A, De La Rosa-Velazquez IA, Ramirez F, Barenboim M, Onishi-Seebacher M, Arand J, et al. Suv39h-dependent H3K9me3 marks intact retrotransposons and silences LINE elements in mouse embryonic stem cells. Mol Cell. 2014;55(2):277–90.
O’Carroll D, Scherthan H, Peters AH, Opravil S, Haynes AR, Laible G, et al. Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell Biol. 2000;20(24):9423–33.
Saccani S, Natoli G. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev. 2002;16(17):2219–24.
Mal AK. Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation. EMBO J. 2006;25(14):3323–34.
Scarola M, Comisso E, Pascolo R, Chiaradia R, Maria Marion R, Schneider C, et al. Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. Nat Commun. 2015;6:7631–3.
Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG, et al. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene. 2013;32(11):1351–62.
Yang YJ, Han JW, Youn HD, Cho EJ. The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res. 2010;38(2):382–90.
Cherrier T, Suzanne S, Redel L, Calao M, Marban C, Samah B, et al. p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene. 2009;28(38):3380–9.
Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26(3):317–25.
Wettenhall JM, Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004;20(18):3705–6.
Pan Z, Wang Z, Yang H, Zhang F, Reinach PS. TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2011;52(1):485–93.
Chen G, Deng X. Cell synchronization by double thymidine block. Bio Protoc. 2018;8(17): e2994.
Liang N, Liu XD, Zhang S, Sun H. The role of Beclin 1 in IR-induced crosstalk between autophagy and G2/M cell cycle arrest. Cell Signal. 2019;62:109353.
Matthaei M, Meng H, Bhutto I, Xu Q, Boelke E, Hanes J, et al. Systematic assessment of microneedle injection into the mouse cornea. Eur J Med Res. 2012;17(1):19.
Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013;14(8):518–28.
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314–21.
Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet. 2011;12(1):7–18.
Du J, Johnson LM, Jacobsen SE, Patel DJ. DNA methylation pathways and their crosstalk with histone methylation. Nat Rev Mol Cell Biol. 2015;16(9):519–32.
Gao J, Wang Y, Zhao X, Chen P, Xie L. MicroRNA-204-5p-mediated regulation of SIRT1 contributes to the delay of epithelial cell cycle traversal in diabetic corneas. Invest Ophthalmol Vis Sci. 2015;56(3):1493–504.
Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science. 2007;317(5845):1760–4.
Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484–92.
Hsia DA, Tepper CG, Pochampalli MR, Hsia EY, Izumiya C, Huerta SB, et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci U S A. 2010;107(21):9671–6.
Guerrero-Juarez CF, Astrowski AA, Murad R, Dang CT, Shatrova VO, Astrowskaja A, et al. Wound regeneration deficit in rats correlates with low morphogenetic potential and distinct transcriptome profile of epidermis. J Invest Dermatol. 2018;138(6):1409–19.
Lv L, Sun Y, Han X, Xu CC, Tang YP, Dong Q. Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition. Brain Res. 2011;1396:60–8.
Wang G, Badylak SF, Heber-Katz E, Braunhut SJ, Gudas LJ. The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice. Regen Med. 2010;5(2):201–20.
Lawrence M, Daujat S, Schneider R. Lateral thinking: how histone modifications regulate gene expression. Trends Genet. 2016;32(1):42–56.
Yu T, Wang C, Yang J, Guo Y, Wu Y, Li X. Metformin inhibits SUV39H1-mediated migration of prostate cancer cells. Oncogenesis. 2017;6(5): e324.
Chiba T, Saito T, Yuki K, Zen Y, Koide S, Kanogawa N, et al. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Int J Cancer. 2015;136(2):289–98.
Shuai W, Wu J, Chen S, Liu R, Ye Z, Kuang C, et al. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter. Cancer Lett. 2018;422:56–69.
Spyropoulou A, Gargalionis A, Dalagiorgou G, Adamopoulos C, Papavassiliou KA, Lea RW, et al. Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation. Neuromolecular Med. 2014;16(1):70–82.
Yokoyama Y, Hieda M, Nishioka Y, Matsumoto A, Higashi S, Kimura H, et al. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo. Cancer Sci. 2013;104(7):889–95.
Greiner D, Bonaldi T, Eskeland R, Roemer E, Imhof A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol. 2005;1(3):143–5.
Cherblanc FL, Chapman KL, Reid J, Borg AJ, Sundriyal S, Alcazar-Fuoli L, et al. On the histone lysine methyltransferase activity of fungal metabolite chaetocin. J Med Chem. 2013;56(21):8616–25.
Wojtala M, Macierzynska-Piotrowska E, Rybaczek D, Pirola L, Balcerczyk A. Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells. Pharmacol Res. 2018;128:252–63.
Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14(2):159–69.
Chung EH, Hutcheon AE, Joyce NC, Zieske JD. Synchronization of the G1/S transition in response to corneal debridement. Invest Ophthalmol Vis Sci. 1999;40(9):1952–8.
Bao JM, He MY, Liu YW, Lu YJ, Hong YQ, Luo HH, et al. AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation. Am J Cancer Res. 2015;5(5):1741–50.
Nakamura M, Wu L, Griffin JD, Kojika S, Goi K, Inukai T, et al. Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors. Leuk Res. 2018;72:34–44.
Zieske JD. Expression of cyclin-dependent kinase inhibitors during corneal wound repair. Prog Retin Eye Res. 2000;19(3):257–70.
We thank Araki Sasaki Kagoshima (Miyata Eye Clinic, Kagoshima, Japan) for the kind gift of the human corneal epithelial cell line.
This work was supported, in part, by the 973 Project from the Ministry of Science and Technology of China (Grant No. 2012CB722303), National Natural Science Foundation of China (Grant No. 81700801), Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ15H160014), Science Foundation of Wenzhou Medical University (Grant No. QTJ11020), and Zhejiang Provincial Natural Science Foundation of China (Grant No. LY21H120005).
Ethics approval and consent to participate
All animal treatments were performed in strict accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and with approval from the Wenzhou Medical University Animal Care and Use Committee (ID Number: wydw2019–0385).
Consent for publication
Jia Qu is the editor in chief and Peter S. Reinach is the editorial board member of the journal. The other authors have no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Gene ontology (GO) enrichment analysis of differentially expressed epigenetic modifiers during corneal epithelial wound healing (CEWH). The top 15 most significant enriched GO functional terms are shown. The X-axis shows different gene function terms, including biological process (red), cellular component (blue), and molecular function (green).
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of altered epigenetic modifiers during corneal epithelial wound healing (CEWH). The top 10 most enriched signaling pathways in differentially expressed epigenetic modifiers are shown. The Y-axis shows different signaling pathways. Bubbles of various sizes and hues represent the corresponding amounts of altered epigenetic modifiers enriched in a signaling pathway and their significance.
SUV39H1 knockdown leads to G1 phase arrest in human corneal epithelial cells (HCECs). HCECs transfected with NC or SUV39H1 siRNA were cultured in DMEM/F12 medium containing 2 mmol/L thymidine for 16 h. Then, HCECs were cultured in normal DMEM/F12 medium without thymidine for 9 h after twice PBS washing. After an additional twice PBS wash, HCECs were again subjected to 2 mmol/L thymidine for 16 h. After twice PBS wash, HCECs were again cultured in normal medium to be collected at the relevant time points after being released from the thymidine block to detect cell cycle distribution via flow cytometry. Representative results are shown.
Knockdown of SUV39H1 via another siRNA inhibits human corneal epithelial cell (HCEC) proliferation and induces G1 cell cycle arrest. a The mRNA levels of SUV39H1, p27, and p21 in HCECs were measured at 48 h after transfection with irrelevant negative control (NC) or SUV39H1 siRNA (n = 3/group) via RT-qPCR. b The protein levels of cell cycle regulators were detected at 48 h after siRNA transfection in HCECs by Western blotting. c Densitometric Western blotting analysis quantifying the protein expression in transfected HCECs was performed (n = 3/group). d MTS assay evaluated cell proliferation in HCECs with the transfection of NC or SUV39H1 siRNA at different time points (n = 6/group). e Flow cytometry determined the effect of SUV39H1 on cell cycle distribution in HCECs at 24 h after release from the second thymidine block. Representative results are shown. f Representative images of EdU staining in HCECs transfected with NC or SUV39H1 siRNA. Red: EdU; blue: Hoechst 33342; scale bar is 50 μm. g Histogram of the percentage of EdU positive cells showing the proliferating cells in NC or SUV39H1 siRNA transfected HCECs (n = 4/group).
SUV39H1 expression decreased with the presence of SUV39H1 siRNA in murine corneal epithelium during corneal epithelial wound healing (CEWH). RT-qPCR was used to analyze the expression levels of SUV39H1 in the negative control (NC) and the SUV39H1 siRNA-injected groups (n = 3/group).
SUV39H1 repression with a different siRNA remarkedly delays corneal epithelial wound closure. a The expression level of SUV39H1 in the corneal epitheliums of negative control (NC) and the SUV39H1 siRNA-injected groups were quantified by RT-qPCR (n = 4/group). b Representative images of fluorescein sodium-stained corneas in SUV39H1 siRNA or NC injected groups. c Scatter plots of residual epithelial defects of corneas in SUV39H1 siRNA and NC injected groups (n = 7/group). The remaining wound areas are presented in pixels of size.
Expression of cell cycle associated genes in human corneal epithelial cells (HCECs) transfected with SUV39H1 siRNA. RT-qPCR was used to systematically analyze the alteration of cell cycle associated genes in HCECs at 48 h after transfection with negative control (NC) or SUV39H1 siRNA.
SUV39H1 repression significantly decreases the phosphorylation level of Rb, Cyclin D1, and CDK6 in human corneal epithelial cells (HCECs). a Western blotting detected the protein levels of Cyclin D1, CDK2, CDK4, and CDK6 in NC or SUV39H1 siRNA transfected HCECs. b The protein levels of Cyclin D1 and CDKs were quantified from three independent replicates. c Histogram of normalized mean fluorescence intensity of CDK6 in NC siRNA or SUV39H1 siRNA transfected HCECs by fluorescence activated cell sorting (FACS) (n = 3/group). d Representative result of CDK6 in FACS is shown in HCECs after siRNA transfection. e Histogram of normalized positive p-Rb cells in negative control (NC) or SUV39H1 siRNA transfected HCECs (n = 4/group) via FACS. The percentage of positive p-Rb cells in HCECs transfected with NC siRNA acted as the normalized control. f Representative line chart of the positive p-Rb cells in HCECs transfected with NC or SUV39H1 siRNA via FACS.
SUV39H1 directly binds to the p27 and p21 promoters in human corneal epithelial cells (HCECs). Chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR) was performed to analyze SUV39H1 occupancy at the p27 and p21 promoters at 48 h after siRNA transfection in HCECs (n = 3/group). The percentage (%) of the input signal is used to express the results.
Genes included in NanoString probe set.
Primers used for RT-qPCR analysis.
ChIP-qPCR primers used for candidate gene promoters.
Differentially expressed epigenetic modifiers during CEWH.
About this article
Cite this article
Yang, S., Chen, W., Jin, S. et al. SUV39H1 regulates corneal epithelial wound healing via H3K9me3-mediated repression of p27. Eye and Vis 9, 4 (2022). https://doi.org/10.1186/s40662-022-00275-5